Qualitative and Quantitative Assessment of Marginal Bone Loss Following Flapless Guided Versus Conventional Implant Placement
1 other identifier
interventional
10
1 country
1
Brief Summary
Marginal bone preservation is an important determinant of long-term implant success. Conventional flap implant placement provides direct visualization of the surgical site but may disturb the periosteal blood supply and contribute to early crestal bone remodeling. Flapless guided implant placement is a minimally invasive approach that aims to preserve soft tissue architecture and vascular integrity. CBCT allows three-dimensional evaluation of peri implant bone levels, including mesial, distal, buccal, and lingual aspects. Aim: The aim of this study was to compare flapless guided implant placement with conventional flap implant placement in terms of marginal bone loss, implant stability, postoperative pain, and soft-tissue healing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 17, 2026
CompletedFirst Posted
Study publicly available on registry
June 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
CompletedJune 23, 2026
June 1, 2026
1 year
June 17, 2026
June 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Marginal Bone Loss
CBCT assessment
baseline, 3 months, 6 months
Secondary Outcomes (2)
Implant Stability ISQ
baseline, 3 months, 6 months
Postoperative Pain Assessment VAS scale 0-10
baseline, Day 2 Day 3 Day 4 Day 5
Study Arms (2)
Flapless Guided Implant Placement
EXPERIMENTALConventional Flap Implant Placement
EXPERIMENTALInterventions
manually raising the gingival tissue during dental implant surgery, this surgical procedure involves the placement of a dental implant directly into the alveolar or basal bone during a single session followed by the placement of a healing abutment without the use of surgical guides or advanced technology.
a minimally invasive dental implant procedure where a surgical guide, often created using advanced imaging techniques like cone-beam computed tomography (CBCT) and computer-aided design (CAD), directs the precise placement of dental implants without the need for traditional flap elevation.
Eligibility Criteria
You may qualify if:
- Patients aged 20 years or older.
- Patients requiring at least two dental implants within the same arch.
- Patients with good general health and able to undergo oral surgery.
- Patients willing to participate in the study and provide informed consent.
- Patients with adequate bone volume for implant placement as determined by preoperative radiographic assessment (e.g., cone beam computed tomography).
You may not qualify if:
- Patients with systemic diseases that could compromise healing or implant success (e.g., uncontrolled diabetes, immunocompromised conditions).
- Patients with a history of radiation therapy to the head and neck region.
- Patients with active periodontal disease or untreated oral infections.
- Patients who are pregnant or breastfeeding.
- Patients with a history of bisphosphonate therapy or other medications that may affect bone metabolism.
- Smoker Patients with a history of smoking or heavy alcohol consumption.
- Patients with unrealistic expectations or inability to comply with postoperative care instructions.
- Patients with significant facial trauma or anatomical deformities affecting the implant site.
- Patient who requires Immediate implant placement
- Thin gingival biotype
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gulf Medical University
Ajman, Ajman Emirate, 00000, United Arab Emirates
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2026
First Posted
June 23, 2026
Study Start
July 1, 2025
Primary Completion
July 1, 2026
Study Completion
July 30, 2026
Last Updated
June 23, 2026
Record last verified: 2026-06